• Study of Atezolizumab and Chemotherapy for Patients with Relapsed Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated diseases:
    Italy
  • Study on Baricitinib for Patients with Calcium Pyrophosphate Deposition Disease (CPPD) Using Methotrexate Sodium and Drug Combination

    Recruiting

    2 1 1 1
    Italy
  • Study on the Effects of Dapagliflozin on Kidney Health in Patients with Chronic Kidney Disease After Kidney Transplantation

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • Study Comparing Cyclophosphamide, Azathioprine, and Tacrolimus for Patients with Antisynthetase Syndrome-Related Interstitial Lung Disease

    Recruiting

    3 1 1 1
    Investigated diseases:
    France
  • Title: Comparing tebentafusp treatment versus observation in patients with high-risk eye melanoma (uveal melanoma) after initial treatment

    Recruiting

    3 1 1 1
    Investigated drugs:
    Belgium France Germany Ireland Italy The Netherlands +3
  • Study on Anifrolumab and Phototherapy for Adults with Progressive Vitiligo

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France
  • Study on the Safety and Effectiveness of CABA-201, Fludarabine Phosphate, and Cyclophosphamide in Patients with Active Systemic Lupus Erythematosus

    Recruiting

    2 1 1 1
    Investigated diseases:
    France Spain
  • Study of drug combination therapy in asymptomatic patients with frequent premature ventricular contractions and normal heart function to prevent left ventricular dysfunction

    Recruiting

    3 1 1 1
    Investigated diseases:
    France
  • Study of Temozolomide and Lomustine Followed by Radiotherapy versus Standard Treatment in Patients with Newly Diagnosed Grade 2 or 3 Glioma

    Recruiting

    3 1 1 1
    Investigated diseases:
    Germany
  • Study comparing BCG and combination of BCG with electromotive mitomycin-C treatment in patients with high-risk non-muscle-invasive bladder cancer

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

powered by